Lambert‑Eaton myasthenic syndrome and small cell lung cancer – case report
02/2021
MUDr. Daniel Krejčí1; MUDr. Lukáš Hruška2
1 Klinika pneumologie 3. LF UK a Fakultní nemocnice Na Bulovce, Praha
2 Neurologické oddělení, Fakultní nemocnice Na Bulovce, Praha
SUMMARY
Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune, presynaptic disorder of neuromuscular transmission characterized by fluctuating muscle weakness, autonomic dysfunction and depressed tendon reflexes.1 The coappearance with small cell lung cancer happens to be typical and sometimes the symptoms may precede the radiological cancer confirmation. There is a symptomatic therapy of LEMS as a complement of the causal cancer treatment. This case report presents patient with Lambert-Eaton myasthenic syndrome and concurrent atypical long small cell lung cancer survival.
Key words
LEMS, small cell lung cancer
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...